2m 2m 2m 2m 2m 2m 2m
CRISPR THERAP N (CRSP)
NASDAQ
$48.34+$0.35 (+0.73%)
Price as of Aug 03, 2026 4:39 AM EDT- $4.7BMarket Cap
- -14.44%1-Year Change
- BiotechnologyIndustry
CRISPR THERAP N (CRSP)
$48.34+$0.35 (+0.73%)
Earnings Score
Valuation | CRSP | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | CRSP | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 6.84% | ||
12-Month Momentum | -1.14% | ||
3-Month Risk Adjusted Momentum | 30.30% | ||
12-Month Risk Adjusted Momentum | -2.01% |
True Yield
Valuation | CRSP | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | -0.68% | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | CRSP | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 6 |